Retinal vasculature in hypertension
高血压患者的视网膜血管
基本信息
- 批准号:10701665
- 负责人:
- 金额:$ 36.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAdultAngiotensin IIAntihypertensive AgentsAreaBasement membraneBlood PlateletsBlood PressureBlood VesselsBlood capillariesBlood flowBlood-Retinal BarrierCD31 AntigensChronicCollagenConnexin 43DataDependenceDesminDevelopmentDiseaseE-SelectinEndothelial CellsEndothelin-1EndotheliumEventExtracellular MatrixEyeFemaleFibronectinsFunctional disorderFutureGlycocalyxGlycoproteinsGlypicanGonadal Steroid HormonesHealthHemorrhageHypertensionHypertensive RetinopathyHypoxiaInbred SHR RatsInbred WKY RatsKDR geneKnowledgeLeukocytesMediatorMesenchymalMicrocirculationModelingMolecularN-CadherinNamesOptic DiskOxygenPathologicPathway interactionsPerfusionPharmaceutical PreparationsPhenotypePlatelet GlycoproteinsPopulationPredispositionPrevalenceProteoglycanRecoveryRetinaRetinal Artery OcclusionRetinal DiseasesRisk FactorsS100A4 geneSmooth MuscleSmooth Muscle MyocytesSurfaceSwellingTestingThinnessThrombusUnited StatesVascular Cell Adhesion Molecule-1VasodilationVimentinVisionWorkarterioleblood pressure reductioncadherin 5collagenasecotton wool spotsdriving forceendothelial dysfunctionexperimental studyhypertensivemalemigrationmoesinmuscle degenerationnegative affectnormotensivenoveloptical discpharmacologicpressurepreventresponseretina blood vessel structureretina circulationretinal neuronsexsyndecantherapeutically effectivevein occlusionvon Willebrand factor receptor
项目摘要
Approximately 32-44% of the adult US population has hypertension, with one of the many complications
being hypertensive retinopathy. In one study, the prevalence of retinopathy was found to be 85% amongst
those with severe hypertension, and 25% for those with mild hypertension. Retinal consequences of
hypertension include arteriolar narrowing, hemorrhages, cotton wool spots (localized hypoxia), and optic
disk swelling. Other retinal changes include hyalinization of arteriolar walls, thickening of the vascular
basement membrane, closure of capillaries, smooth muscle degeneration, and blood-retinal barrier
dysfunction. Additionally, hypertension is a major risk factor for the highly threatening events of retinal artery
or vein occlusion. The primary treatment for hypertensive retinopathy is to reduce blood pressure; however,
consequences of the disease including narrowing of arterioles persist even following anti-hypertension
medication. Therefore, a better knowledge of the mechanisms of the disease could lead to the development
of additional and more effective therapeutic options. Our overall hypothesis is that the vascular
complications of hypertensive retinopathy are due phenotypic changes in endothelial and smooth muscle
cells, with vessel wall remodeling limiting recovery even with anti-hypertensive medication. The specific
aims are to: (1) determine the sex-dependent expression of the glycocalyx in the retina, and determine the
consequences of hypertension on this expression, (2) examine the sex-dependent expression of platelet
endothelial adhesion molecule-1 and vascular endothelial cadherin in the retina, and test the hypothesis
that changes in these junctional molecules in the hypertensive retina are due to endothelial-to-
mesenchymal transition, and (3) test the hypothesis that remodeling of blood vessel walls in the SHR retina
induces susceptibility to poor retinal perfusion when high blood pressure is reduced to normal.
大约32-44%的美国成年人患有高血压,并伴有多种并发症之一
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Decreased retinal and choroidal endothelial surface molecules in spontaneously hypertensive rats.
- DOI:10.1016/j.exer.2023.109617
- 发表时间:2023-08
- 期刊:
- 影响因子:3.4
- 作者:Randa S. Eshaq;Minsup Lee;Wendy Leskova;Norman R. Harris
- 通讯作者:Randa S. Eshaq;Minsup Lee;Wendy Leskova;Norman R. Harris
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORMAN R HARRIS其他文献
NORMAN R HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORMAN R HARRIS', 18)}}的其他基金
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 36.5万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 36.5万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 36.5万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 36.5万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 36.5万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 36.5万 - 项目类别:














{{item.name}}会员




